---
title: "Super Micro Computer | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 5.018 B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264286432.md"
datetime: "2025-11-04T21:20:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264286432.md)
  - [en](https://longbridge.com/en/news/264286432.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264286432.md)
generator: "portal-rs"
---

# Super Micro Computer | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 5.018 B

Revenue: As of FY2026 Q1, the actual value is USD 5.018 B, missing the estimate of USD 5.795 B.

EPS: As of FY2026 Q1, the actual value is USD 0.26, missing the estimate of USD 0.2738.

EBIT: As of FY2026 Q1, the actual value is USD 233.48 M.

### Financial Metrics by Segment

#### Segment Revenue

-   Net sales for Q1 FY2026 were $5.0 billion, compared to $5.8 billion in Q4 FY2025 and $5.9 billion in Q1 FY2025.

#### Operational Metrics

-   Gross margin for Q1 FY2026 was 9.3%, down from 9.5% in Q4 FY2025 and 13.1% in Q1 FY2025.
-   Net income for Q1 FY2026 was $168 million, compared to $195 million in Q4 FY2025 and $424 million in Q1 FY2025.
-   Operating expenses for Q1 FY2026 were $285.1 million, compared to $266.4 million in Q1 FY2025.
-   Income from operations for Q1 FY2026 was $182.3 million, compared to $509.2 million in Q1 FY2025.

#### Cash Flow

-   Cash flow used by operations for Q1 FY2026 was - $918 million.
-   Capital expenditures for Q1 FY2026 were $32 million.

#### Unique Metrics

-   Total cash and cash equivalents as of September 30, 2025, were $4.2 billion, with total bank debt and convertible notes at $4.8 billion.

#### Outlook / Guidance

-   The company expects net sales of $10.0 billion to $11.0 billion for Q2 FY2026, with GAAP net income per diluted share of $0.37 to $0.45 and non-GAAP net income per diluted share of $0.46 to $0.54.
-   For FY2026, the company anticipates at least $36.0 billion in net sales.

### Related Stocks

- [SMCI.US](https://longbridge.com/en/quote/SMCI.US.md)

## Related News & Research

- [SHRIPISTON: Strong topline growth accompanies diversification, while acquisition costs weigh on margins](https://longbridge.com/en/news/303827844.md)
- [386,130 BlackRock Debt Strategies Fund, Inc. $DSU Shares Sold by Greenup Street Wealth Management LLC](https://longbridge.com/en/news/303829175.md)
- [The Goldman Sachs Group, Inc. $GS Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al](https://longbridge.com/en/news/303827786.md)
- [Dodla Dairy Limited (NSE:DODLA) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year](https://longbridge.com/en/news/303820105.md)
- [Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial.](https://longbridge.com/en/news/303820254.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**